Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis

Neurology Reviews. 2012 June;20(6):

July 1, 2012|Multiple Sclerosis Hub